木犀草素通过SLC7A11/GPX4信号通路调控铁死亡缓解血管平滑肌细胞衰老
CSTR:
作者:
作者单位:

(1.解放军医学院,北京 100853;2.中国人民解放军总医院第二医学中心老年医学研究所,北京 100853;3.南开大学医学院临床医学系,天津 300071)

作者简介:

通讯作者:

中图分类号:

基金项目:

国家重点研发计划(2022YFC3602400)


Luteolin attenuates vascular smooth muscle cell senescence by regulating ferroptosis through SLC7A11/GPX4 signaling pathway
Author:
Affiliation:

(1.Chinese PLA Medical School, Beijing 100853, China;2.Institute of Geriatrics, Second Medical Center, Chinese PLA General Hospital, Beijing 100853, China;3. Faculty of Clinical Medicine, School of Medicine, Nankai University, Tianjin 300071, China)

Fund Project:

This work was supported by the National Key Research and Development Program of China(2022YFC360240O).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨木犀草素(Lut)通过溶质载体家族7成员11(SLC7A11)/谷胱甘肽过氧化物酶4(GPX4)信号通路调控铁死亡进而缓解血管平滑肌细胞(VSMCs)衰老的分子机制,为血管衰老相关疾病的防治提供新思路。方法 使用小鼠主动脉血管平滑肌细胞进行体外实验,设置空白对照组(Con组)、木犀草素组(Lut组,5μmol/L Lut处理24 h)、多柔比星组(DOX组,1μmol/L DOX处理24h)和联合处理组(DOX+Lut组,5μmol/L Lut预处理24h后加入DOX)。使用β-半乳糖苷酶(SA-β-gal)染色试剂盒和细胞计数试剂盒-8(CCK-8)评价细胞衰老与活力,Western blot检测衰老蛋白(P53、P21、P16)及铁死亡通路蛋白(SLC7A11、GPX4),流式细胞术检测活性氧(ROS)水平,脂质过氧化荧光探针和FerroOrang亚铁离子荧光探针分别检测脂质过氧化和细胞内Fe2+,同时测定细胞裂解液内谷胱甘肽(GSH)和丙二醛(MDA)含量。通过SLC7A11抑制剂Erastin干预铁死亡观察衰老表型变化。采用GraphPad Prism 10.0软件进行数据分析,多组间比较采用单因素方差分析,结合Tukey事后检验;两组间比较采用双尾独立样本t检验。结果 与Con组相比,DOX组细胞活力显著下降,IC50值为1.799μmol/L,SA-β-gal阳性衰老细胞比例显著升高至63%(P<0.05);同时伴随衰老蛋白(P53、P21、P16)表达上调,ROS及脂质过氧化水平显著增加,Fe2+发生明显蓄积,GSH含量降低,SLC7A11和GPX4蛋白表达显著下调(P<0.05)。与DOX组相比,DOX+Lut组上述指标均有明显改善,IC50值提升至2.192μmol/L,衰老细胞比例降至约38%,且SLC7A11与GPX4的表达明显恢复(P<0.05)。结论 Lut激活SLC7A11/GPX4信号,可有效抑制DOX诱导的铁死亡并缓解VSMCs衰老,可为防治血管衰老相关疾病提供新的理论依据。

    Abstract:

    Objective To investigate the molecular mechanism by which luteolin (Lut) alleviates vascular smooth muscle cells (VSMCs) senescence by regulating ferroptosis via the solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) signaling pathway, thereby providing novel insights for the prevention and treatment of vascular aging-related diseases. MethodsMouse vascular smooth muscle cells (MOVAS) were subjected and randomly divided into blank control group (Con group), Lut group (5 μmol/L Lut for 24 h), doxorubicin group (DOX group, 1 μmol/L DOX for 24 h), and combined treatment group (DOX+Lut group, pretreatment of 5 μmol/L Lut for 24 h followed by DOX treatment). Cell senescence and viability were evaluated using senescence-associated β-galactosidase (SA-β-gal) staining and cell counting kit-8 (CCK-8) assay, respectively. The expression of senescence-related proteins (P53, P21, P16) and ferroptosis pathway proteins (SLC7A11, GPX4) was detected by Western blot. Reactive oxygen species (ROS) production was measured by flow cytometry. Lipid peroxidation and intracellular ferrous iron (Fe2+) levels were detected using lipid peroxidation fluorescent probes and FerroOrange fluorescent probe, respectively. Additionally, glutathione (GSH) and malondialdehyde (MDA) contents in cell lysates were measured. SLC7A11 inhibitor Erastin was used to intervene ferroptosis to observe the changes in senescence phenotypes. GraphPad Prism 10.0 software was employed for data analysis. Multiple-group comparison was performed using one-way ANOVA followed by Tukey′s post hoc test, and intergroup comparison was applied using a two-tailed independent sample t test. Results Compared with the Con group, the DOX group exhibited significantly decreased cell viability (IC50=1.799 μmol/L) and an obviously increased proportion of SA-β-gal-positive senescent cells (approximately 63%, P<0.05), accompanied with upregulated senescence proteins (P53, P21, P16), elevated ROS and lipid peroxidation levels, marked accumulation of Fe2+, reduced GSH content, and notably downregulated expression of SLC7A11 and GPX4 proteins (P<0.05). The addition of Lut pretreatment remarkably improved the aforementioned indicators, such as the IC50 value increasing to 2.192 μmol/L, the proportion of senescent cells decreasing to approximately 38%, and restored protein levels of SLC7A11 and GPX4 when compared with the levels in the DOX group (P<0.05). Conclusion Lut effectively inhibits DOX-induced ferroptosis and alleviates VSMC senescence by activating the SLC7A11/GPX4 signaling pathway, providing a theoretical basis for the treatment of vascular aging-related diseases.

    参考文献
    相似文献
    引证文献
引用本文

陈斯佳,芦婷婷,王绫欢,殷会佳,李迎雷,王天虎,周洋,孙乃媛,沈晓影,曹丰.木犀草素通过SLC7A11/GPX4信号通路调控铁死亡缓解血管平滑肌细胞衰老[J].中华老年多器官疾病杂志,2026,25(3):215-221
DOI:10.11915/j. issn.1671-5403.2026.03.045

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-08-29
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-03-09
  • 出版日期:
文章二维码